PD-L1 expression as a potential predictive biomarker

Lancet Oncol. 2015 Oct;16(13):1285-7. doi: 10.1016/S1470-2045(15)00307-1.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • B7-H1 Antigen / analysis*
  • B7-H1 Antigen / antagonists & inhibitors
  • B7-H1 Antigen / immunology
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / immunology
  • Humans
  • Immunotherapy / methods
  • Lung Neoplasms / chemistry*
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / immunology
  • Lung Neoplasms / pathology
  • Melanoma / chemistry*
  • Melanoma / drug therapy
  • Melanoma / immunology
  • Melanoma / pathology
  • Patient Selection
  • Predictive Value of Tests
  • Skin Neoplasms / chemistry*
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human